Hypershell secures an additional $50 million in a $120 million Series B round as consumer exoskeletons move beyond a niche market.

      Ant Group and Meituan Dragonball jointly led a $50 million Series B+ funding round, with contributions from Sofina and Granite Asia. Cumulatively, the Series B funding has reached a total of $120 million at a near-$400 million post-money valuation, ahead of the global launch of the X-Series scheduled for Wednesday.

      Hypershell, a consumer exoskeleton company based in Shanghai, has successfully secured a $50 million Series B+ funding round co-led by Ant Group and Meituan Dragonball, also referred to as DragonBall Capital in the announcement. Sofina and Granite Asia also took part in this funding round. Cygnus Equity acted as the exclusive financial advisor.

      This round represents the second tranche of a Series B funding that has brought the total amount raised by the company to $120 million at an almost $400 million post-money valuation, as confirmed separately by Yicai Global.

      The defining aspect of this financing round is its timing. As Hypershell disclosed, the broader Series B was completed within a twelve-month period, including $70 million raised in pre-B and B rounds in November 2024, led by Luminous Ventures and 5Y Capital, followed by the recent $50 million Series B+.

      This timeline indicates that Ant Group and Meituan Dragonball invested when Hypershell’s unit economics transitioned from demonstrating product-market fit to scaling for volume.

      Hypershell’s X series is claimed by the company to be the first consumer exoskeleton to rank first on Amazon in both sales volume and market share in the US and Europe.

      The product’s story began to emerge back in 2023 when Hypershell launched its first consumer-grade exoskeleton on Kickstarter, achieving over $1.23 million in pledges from 2,638 backers.

      The initial device converted medical and industrial exoskeleton technology into a compact, sub-2kg wearable aimed at hikers, travelers, athletes, and elderly users with mobility challenges.

      Independent reviewers, including Fast Company’s gear desk, tested the product in various consumer scenarios and reported results aligning with the company’s claims of a 30% decrease in physical exertion and around a 40% increase in effective leg strength.

      The new product, the New Hypershell X Series, is set to launch globally at 13:00 BST on Wednesday, May 20. Its main technical innovation is HyperIntuition, the company’s proprietary AI motion-control algorithm, which Hypershell states allows movement beyond preset gait patterns, functioning as a closed-loop perception-recognition-prediction-planning system that interprets user intent in real time.

      Additionally, Hypershell emphasizes that this series is the first end-to-end consumer exoskeleton certified by TÜV Rheinland, which the company positions as a regulatory-quality benchmark as this product category advances into mass-market sales channels.

      Founded in 2021 by Kelvin Sun, the engineer behind hardware venture Lattepanda, Hypershell’s team operates from Beijing and Shenzhen, employing around 100 staff. "Hypershell began with a straightforward vision: to help people go farther," said Sun in the announcement, highlighting the company's reach into over 70 countries since its inception.

      The mix of strategic investors will influence future developments. Ant Group, part of Alibaba's ecosystem, specializes in consumer data and payment platforms, while Meituan Dragonball functions as the early-stage venture arm of the Meituan superapp. Both investors have significant distribution capabilities, with Ant's Alipay and Meituan's logistics and services networks providing Hypershell with unexpected avenues into the Chinese consumer market, which has historically been challenging for hardware-led brands. Sofina and Granite Asia offer continuity stemming from the Western retail traction the company has already achieved.

      The broader competitive landscape includes China's expanding focus on robotics, which has intensified as we approach 2026. Barclays recently assessed that humanoid robots could potentially counter as much as 60% of China’s projected decline in its labor force of 37 million workers by 2035.

      Hypershell operates in a different category than that of humanoid robots: while Unitree’s GD01 and its $7 billion IPO filing represent a comparable bet in the bipedal-humanoid segment, consumer exoskeletons aim to enhance rather than replace human capabilities. Although these two product categories compete for separate budget lines, they share overlapping narratives among investors.

      One aspect not covered in the press release is the ongoing question of customer satisfaction versus supply curve issues that have complicated the broader Chinese consumer robotics market. Recent independent surveys indicate that buyer satisfaction among humanoid robot manufacturers stands at just 23% across more than 150 active companies. Hypershell’s claim of leadership on Amazon serves as a significant data point against this trend, but the upcoming launch of the New X Series will be the company’s first product release with both the new funding and strategic distribution partnerships in place. Whether Hypershell can achieve a successful and